SF 751
Status in the Senate - 90th Legislature (2017 - 2018)
Revisor number: 17-2409
Bill Text Versions
| Engrossments | ||
|---|---|---|
|
Introduction
PDF
|
Posted on 02/07/2017 | |
|
1st Engrossment
PDF
|
Posted on 03/07/2017 | |
|
2nd Engrossment
PDF
|
Posted on 05/10/2017 |
Description
Prescription opioids label disclosures requirement
Authors
Actions
Senate
| 02/09/2017 | |
| 02/09/2017 |
Referred to
Health and Human Services Finance and Policy
|
| 03/07/2017 | |
| 05/10/2017 | |
| 05/10/2017 |
Second reading
pg. 4493
|
|
See
First Special Session, SF2, Art. 12, Sec. 1
|
| Senate Actions | House Actions |
|---|---|
| 02/09/2017 | |
|
Referred to
Health and Human Services Finance and Policy
|
|
| 03/07/2017 | |
| 05/10/2017 | |
|
Second reading
pg. 4493
|
|
| Final Actions | |
|
See
First Special Session, SF2, Art. 12, Sec. 1
|
|